Elisabeth Sörstadius

Statistics

Publications

Citations

175

H-Index

Active since

2010

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (Netherlands)

Elisabeth Sörstadius is an author at AstraZeneca (Sweden) specializing in economic burden of disease, healthcare resource utilization, and healthcare utilization measurement.

Publications per year

2010–2021

Publications

A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs loose-dose combination of oral anti-diabetes drugs

Tasneem Lokhandwala, Nancy Smith, C. Sternhufvud et al. · Journal of Medical Economics · 2015 · 53 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications

Anna Rydén, Elisabeth Sörstadius, Klas Bergenheim et al. · PLoS ONE · 2016 · 45 citations · Full text

Medicine, Health Policy, Diabetology +16

The Impact of Upper Gastrointestinal Symptoms on Nonadherence to, and Discontinuation of, Low-Dose Acetylsalicylic Acid in Patients with Cardiovascular Risk

Stephen D. Pratt, VINCENT THOMPSON, Eric P. Elkin et al. · American Journal of Cardiovascular Drugs · 2010 · 40 citations

Medicine, Pharmacology, Pharmacotherapy +6

Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans

Carolyn S.P. Lam, Robert Wood, Muthiah Vaduganathan et al. · Clinical Cardiology · 2021 · 26 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17

Humanistic burden and economic impact of chronic kidney disease: a systematic literature review

Caroline Freeman, Lucia Giles, Polly Field et al. · F1000Research · 2019 · 11 citations · Full text

Pharmacy, Nephrology, Pharmacoeconomics +16

1–5 of 5